Find Articles



Return to:Diabetes Articles
Or:Recent Diabetes Articles

Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting ...


http://news.moneycentral.msn.com/provider/providerarticle...

MSN MoneyCentral - CARLSBAD, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. ISIS today announced that it has added a new diabetes drug targeting the sodium dependent glucose transporter type 2 (SGLT2) to its development pipeline. ISIS 388626, a ...



Article Finder:

October 18, 2007 04:06:00 AM
Article Directory